112P Patients’ knowledge about ductal carcinoma in situEllen G. Engelhardt, Eveline M. A. Bleiker, Miranda A. Gerritsma et al.|Annals of Oncology|2022Cited by 0
The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safeRenée Schmitz, J. Wesseling, N. Bijker et al.|European Journal of Cancer|2022Cited by 0